Interview with Paulino Alonso: ICHQ3D on Elemental impurities

ICHQ3D implementation involves a risk analysis to design strategies to control elemental impurities in drugs for human use, accountability for which lies fully with the owners of the marketing authorisation. The deadline to implement this guideline for elemental impurities expires at the end of 2017.   In this interview, Paulino Alonso, Azierta’s Toxicology team responsible…